Pediatric patients are not only at an increased risk of adverse events, but they are also more likely to experience severe harm when adverse events occur. Unpredictable pharmacokinetics, off-label prescribing, and unintuitive dosing are just some of the complexities of treating the pediatric patient.
Community pharmacists play a pivotal role in ensuring that prescriptions are safe and effective for our pediatric population. This 5-part CCCEP-accredited e-Learning program will provide community pharmacists the fundamentals of assessing pediatric prescriptions, doing common calculations, identifying, and managing high-risk areas in your practice, as well as effectively educating patients and caregivers. Co-designed with the input of pediatric specialists, clinical pharmacists, community pharmacists and consumers, and based on medication incidents from 2016-2021, the topics selected are pertinent to present-day pharmacy practice.
Understanding the unique medication safety considerations when approaching pediatrics from the community pharmacy perspective is key to optimizing the health outcomes of your patients. Upon successful completion of this e-Learning program, learners will gain 2.5 CEUs.
The Canadian Council on Continuing Education in Pharmacy (CCCEP) has accredited this program for 2.5 CEUs for pharmacists; CCCEP # 1231-2022-3399-I-P.
After completing this course, you will be able to:
- Identify pharmacokinetic/pharmacodynamic differences between pediatric and adult patients
- Explain the patient care process when reviewing pediatric prescriptions
- Discuss common calculations used in pediatrics (that may be tricky/difficult)
- Identify high risk medications in pediatrics that require heightened vigilance
- Describe medication incidents that have occurred and approaches to prevent incidents in the future
- Describe counselling tips around safe storage and disposal of pediatric medications.
Who should take this program?
Pharmacists, pharmacy residents, and pharmacy students.
What modules are included?
- Reviewing Pediatric Prescriptions
- Common Calculations
- High Risk Areas in Pediatrics
- Counselling tips
Each module is 30-40 minutes in length – modules can be completed all at once or one at a time. Total duration is about 2.5 to 3 hours. To obtain a statement of completion and continuing education units, completion of the course test and evaluation is required. The program includes links to guidance from pharmacy regulatory authorities across Canada, where available.
Developed by: ISMP Canada and our advisory team listed below.
- Julie Greenall, Director of Projects, ISMP Canada
- Karlson Kennedy, Community Pharmacy Manager
- Dr. Conor McDonnell, Director of Patient Safety & Quality Program
- Paula Orecklin, Patient and Family Advisor
- Renu Roy, Director of Pharmacy
- Melissa Sheldrick, Patient and Family Advisor, ISMP Canada
Program cost: $150 + applicable taxes/person
(For group or student registration, please contact email@example.com for discounted rates)
TO REGISTER, please click the log in button on the top right-hand corner. Please create an account if you are a new user
If you have any questions, please contact firstname.lastname@example.org